BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26453211)

  • 1. Fluorescence Methods for Unraveling Oligomeric Amyloid Intermediates.
    Zijlstra N; Schilderink N; Subramaniam V
    Methods Mol Biol; 2016; 1345():151-69. PubMed ID: 26453211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation and Characterization of α-Synuclein Oligomers.
    Paslawski W; Lorenzen N; Otzen DE
    Methods Mol Biol; 2016; 1345():133-50. PubMed ID: 26453210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the aggregation number of dopamine-induced α-synuclein oligomeric assemblies.
    Zijlstra N; Claessens MM; Blum C; Subramaniam V
    Biophys J; 2014 Jan; 106(2):440-6. PubMed ID: 24461019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence correlation spectroscopy to determine the diffusion coefficient of α-synuclein and follow early oligomer formation.
    Nath S; Deng M; Engelborghs Y
    Methods Mol Biol; 2012; 895():499-506. PubMed ID: 22760336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of α-Synuclein Amyloid Assemblies for Toxicity Experiments.
    Chen SW; Cremades N
    Methods Mol Biol; 2018; 1779():45-60. PubMed ID: 29886526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein.
    Gallea JI; Celej MS
    J Biol Chem; 2014 Sep; 289(39):26733-26742. PubMed ID: 25143382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson's disease genetically related mutants.
    Tosatto L; Horrocks MH; Dear AJ; Knowles TP; Dalla Serra M; Cremades N; Dobson CM; Klenerman D
    Sci Rep; 2015 Nov; 5():16696. PubMed ID: 26582456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes.
    van Maarschalkerweerd A; Vetri V; Vestergaard B
    FEBS Lett; 2015 Sep; 589(19 Pt B):2661-7. PubMed ID: 26297828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein amyloid oligomers act as multivalent nanoparticles to cause hemifusion in negatively charged vesicles.
    Stefanovic AN; Claessens MM; Blum C; Subramaniam V
    Small; 2015 May; 11(19):2257-62. PubMed ID: 25641873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High stability and cooperative unfolding of α-synuclein oligomers.
    Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE
    Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular composition of sub-stoichiometrically labeled α-synuclein oligomers determined by single-molecule photobleaching.
    Zijlstra N; Blum C; Segers-Nolten IM; Claessens MM; Subramaniam V
    Angew Chem Int Ed Engl; 2012 Aug; 51(35):8821-4. PubMed ID: 22806998
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
    Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
    J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.
    Kostka M; Högen T; Danzer KM; Levin J; Habeck M; Wirth A; Wagner R; Glabe CG; Finger S; Heinzelmann U; Garidel P; Duan W; Ross CA; Kretzschmar H; Giese A
    J Biol Chem; 2008 Apr; 283(16):10992-1003. PubMed ID: 18258594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Characteristics of α-Synuclein Oligomers.
    Cremades N; Chen SW; Dobson CM
    Int Rev Cell Mol Biol; 2017; 329():79-143. PubMed ID: 28109332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
    Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
    Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization.
    Marvian AT; Aliakbari F; Mohammad-Beigi H; Ahmadi ZA; Mehrpooyan S; Lermyte F; Nasouti M; Collingwood JF; Otzen DE; Morshedi D
    Int J Biol Macromol; 2020 Jul; 155():543-550. PubMed ID: 32240735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characteristics and membrane interactions of tandem α-synuclein oligomers.
    Dong C; Hoffmann M; Li X; Wang M; Garen CR; Petersen NO; Woodside MT
    Sci Rep; 2018 Apr; 8(1):6755. PubMed ID: 29712958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conformation-switching fluorescent protein probe for detection of alpha synuclein oligomers.
    Hernandez M; Hu Y; Kim JR
    Chem Commun (Camb); 2013 Nov; 49(91):10712-4. PubMed ID: 24100452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tri- and pentamethine cyanine dyes for fluorescent detection of α-synuclein oligomeric aggregates.
    Kovalska VB; Losytskyy MY; Tolmachev OI; Slominskii YL; Segers-Nolten GM; Subramaniam V; Yarmoluk SM
    J Fluoresc; 2012 Nov; 22(6):1441-8. PubMed ID: 22752431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.